Oric Pharmaceuticals, Inc. (ORIC)
13.71
-0.14
(-1.01%)
USD |
NASDAQ |
Mar 06, 16:00
13.74
+0.04
(+0.26%)
After-Hours: 20:00
Oric Pharmaceuticals Cash from Investing (TTM) : -148.03M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| Pfizer Inc. | -1.351B |
| Krystal Biotech, Inc. | -58.42M |
| Olema Pharmaceuticals, Inc. | -108.00M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |